Cite

HARVARD Citation

    Ghandourh, W. et al. (2022). Optimal and actual rates of Stereotactic Ablative Body Radiotherapy (SABR) utilisation for primary lung cancer in Australia. Clinical and translational radiation oncology. pp. 7-14. [Online]. 
  
Back to record